Acquired epidermodysplasia verruciformis: a ten-year anniversary update.

Acquired epidermodysplasia verruciformis: a ten-year anniversary update. Br J Dermatol. 2019 Sep 23;: Authors: Limmer AL, Wu JH, Doan HQ, Rady PL, Tyring SK Abstract Epidermodysplasia verruciformis (EV), a rare dermatologic condition, was first described by Lewandosky and Lutz in 1922. Subsequently, the disease was linked to nonsense mutations in EVER1 and EVER2 which were proposed to enhance susceptibility to EV-specific β-human papillomavirus (HPV) subtypes. However, genetic alterations alone did not adequately explain the propensity for EV to arise in immunocompromised patients, especially those who are human immunodeficiency virus (HIV)-positive or who have undergone transplantation. PMID: 31545504 [PubMed - as supplied by publisher]
Source: The British Journal of Dermatology - Category: Dermatology Authors: Tags: Br J Dermatol Source Type: research